Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02646748
Recruitment Status : Active, not recruiting
First Posted : January 6, 2016
Last Update Posted : December 4, 2020
Sponsor:
Information provided by (Responsible Party):
Incyte Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 7, 2019
Estimated Study Completion Date : December 24, 2021